Daiwa Securities Group
PHVS icon

Daiwa Securities Group’s Pharvaris PHVS Stock Holding History

Daiwa Securities Group’s Portfolio PHVS Stock Details PHVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-213
Closed -$6K – 1373
2025
Q4 		$6K Buy
+213
New +$5.13K ﹤0.01% 1225

Other funds holding PHVS

GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
EFM
EQT Fund Management Luxembourg $1.02B AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Daiwa Securities Group's PHVS Position: Q1 2026 in Review

Daiwa Securities Group sold out of Pharvaris (PHVS) in Q1 2026, closing a stake of 213 shares — an estimated $6K sold.

Daiwa Securities Group first reported a position in PHVS in Q4 2025 and held it in 1 quarter. The position peaked at $6K in Q4 2025. 110 funds tracked by Wall St. Rank hold PHVS as of Q1 2026.

  • Daiwa Securities Group reported no remaining Pharvaris position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 213 Pharvaris shares in Q1 2026, an estimated $6K.
  • Daiwa Securities Group first reported a position in Pharvaris in Q4 2025 and held it in 1 quarter.
  • Daiwa Securities Group's Pharvaris position peaked at $6K in Q4 2025.
  • 110 funds tracked by Wall St. Rank held Pharvaris as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.